Enveda

Enveda is a pioneering biotechnology company that harnesses the power of artificial intelligence to decode nature's vast chemical library and transform it into breakthrough medicines. Founded in 2019 and headquartered in Boulder, Colorado, with additional operations in Hyderabad, India, Enveda has emerged as a clinical-stage company that is fundamentally redefining the drug discovery process. The company operates at the intersection of computational science and natural product chemistry, using AI-powered tools, knowledge graphs, and metabolomics to identify and develop novel therapeutic candidates.

Nearly half of all medicines taken in pill form originate from molecules found in nature, yet the overwhelming majority of the natural world remains unexplored due to the time and enormous cost of traditional drug discovery methods. Enveda's innovative platform can read and translate nature's hidden chemistry at unprecedented speed and scale - approximately four times faster than the industry standard. This differentiated approach has enabled the company to advance multiple clinical candidates across inflammatory, metabolic, and neurosensory diseases, including treatments for atopic dermatitis, asthma, inflammatory bowel disease, and post-weight loss metabolic maintenance. With over $500 million raised and recognition as one of America's Best Startup Employers by Forbes, Enveda is pioneering a new paradigm in pharmaceutical development.